Home › Kanser sa Suso › California
Pag-aaral pangklinika para sa Kanser sa Suso sa California
179 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
- Los Angeles73 pag-aaral
- Baldwin Park44 pag-aaral
- San Francisco43 pag-aaral
- San Diego41 pag-aaral
- Santa Monica28 pag-aaral
- Mountain View26 pag-aaral
- Irvine23 pag-aaral
- Sacramento20 pag-aaral
- Newport Beach16 pag-aaral
- Orange14 pag-aaral
- Santa Rosa11 pag-aaral
- Vallejo10 pag-aaral
- Burbank9 pag-aaral
- Torrance9 pag-aaral
- Fullerton9 pag-aaral
- Concord9 pag-aaral
- Long Beach9 pag-aaral
- Oakland7 pag-aaral
- Richmond7 pag-aaral
- Stockton7 pag-aaral
- Roseville7 pag-aaral
- Santa Clara7 pag-aaral
- Westminster7 pag-aaral
- Huntington Beach6 pag-aaral
- Redwood City6 pag-aaral
- Pleasanton6 pag-aaral
- Fresno6 pag-aaral
- Fremont6 pag-aaral
- Indio6 pag-aaral
- San Jose6 pag-aaral
- Santa Barbara6 pag-aaral
- Anaheim5 pag-aaral
- Modesto5 pag-aaral
- Santa Maria5 pag-aaral
- Pasadena4 pag-aaral
- Glendale4 pag-aaral
- Bakersfield4 pag-aaral
- Riverside4 pag-aaral
- Vacaville4 pag-aaral
- San Marcos4 pag-aaral
- Antioch4 pag-aaral
- San Leandro4 pag-aaral
- Daly City4 pag-aaral
- Whittier4 pag-aaral
- Alhambra4 pag-aaral
- Arden-Arcade4 pag-aaral
- Elk Grove4 pag-aaral
- San Bernardino4 pag-aaral
- Ontario3 pag-aaral
- Salinas3 pag-aaral
- Santa Clarita3 pag-aaral
- Bellflower3 pag-aaral
- Upland3 pag-aaral
- Sunnyvale3 pag-aaral
- Berkeley3 pag-aaral
- San Mateo3 pag-aaral
- Norwalk3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Los Angeles
- Research Site, San Francisco
Nagre-recruitPhase 1/2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope National Medical Center, Duarte
- Cedars-Sinai Medical Center, Los Angeles
- at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06982521A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06840886The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06760819Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Onco Inst of Hope and Innovation, Cerritos
- City of Hope National Medical, Duarte
- Providence Medical Foundation, Fullerton
- at 7 pa
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05827081Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- at 10 pa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- at 20 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Oncology Institute, Long Beach
- Cancer & Blood Research Center, Los Alamitos
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07102381A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
- Stanford Medicine Cancer Center, Stanford
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07701941Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- City of Hope Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- City of Hope at Long Beach Elm, Long Beach
- at 1 pa
Nagre-recruitPhase 2
Edad 70 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT04305834A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- MemorialCare Orange Coast Medical Center, Fountain Valley
- City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
- at 3 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06369285Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- City of Hope Comprehensive Cancer Center, Duarte
- University of California Los Angeles, Los Angeles
- University of California San Diego Moores Cancer Center, San Diego
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- The Oncology Institute of Hope and Innovation, Cerritos
- Ellison Medical Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
- at 3 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06324357Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- California Protons Cancer Therapy Center, San Diego
Nagre-recruitPhase 2
Edad 50 pataas · Kababaihan · Na-update Set 29, 2026 · NCT01766297A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Newport Beach
- at 1 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05877599Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- California Protons Cancer Therapy Center, San Diego
Nagre-recruitPhase 3
Edad 19 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05856773IKS014 in Advanced Solid Tumors That Express HER2
- Hoag Memorial Hospital Presbyterian, Newport Beach
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05872295A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07060807A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Providence Medical Foundation-Oncology ( Site 0020), Fullerton
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Fountain Valley
- Research Site, Glendale
- Research Site, Sacramento
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06103864The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Providence Medical Foundation, Eureka
- Providence Medical Foundation, Santa Rosa
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06377852ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- City of Hope, Duarte
- UC San Diego Moores Cancer Center, La Jolla
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07007559A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
- Community Cancer Institute ( Site 0100), Clovis
- Providence Medical Foundation ( Site 0080), Fullerton
- at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
- Los Angeles Cancer Network, Los Angeles
- Community Clinical Trials, Orange
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT07054190A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07229313Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Marin Cancer Care, Greenbrae
- Loma Linda University, Loma Linda
- Cancer and Blood Research Center, Los Alamitos
- at 3 pa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07214532A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills
Nagre-recruitPhase 1
Edad 18 hanggang 80 · Kababaihan · Na-update Set 23, 2026 · NCT07401381Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Beverly Hills
- Clinical Trial Site, La Jolla
- Clinical Trial Site, Los Alamitos
- at 8 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07085767A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Community Cancer Institute, Clovis
- City of Hope, Duarte
- Epic Care - Emeryville, Emeryville
- at 19 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- City of Hope, Duarte
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- USC/Norris Comprehensive Cancer Center, Los Angeles
- at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 22, 2026 · NCT07287098Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- University of California Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California Davis, Sacramento
- at 2 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 74 · Kababaihan · Na-update Set 21, 2026 · NCT02620852A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Disney Family Cancer Center, Burbank
- City of Hope, Corona
- City of Hope Comprehensive Cancer Center, Duarte
- at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05894239Pulsed Electric Field Ablation for Metastatic Breast Cancer
- University of California San Francisco, San Francisco
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07487844A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- Hoag Memorial Hospital Presbyterian, Newport Beach
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06827236ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- University Of California - San Diego Moores Cancer Center, La Jolla
- Cancer and Blood Specialty Clinic (CBSC), Los Alamitos
- Cedar Sinai - Samuel Oschin Cancer Center, Los Angeles
- at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07173751Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.